STSteven R. Tahan

Steven R. Tahan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Steven R. Tahan has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Quantitative Histopathologic Analysis of Pigmentation and Melanophage Distribution in Dermal Postinflammatory Hyperpigmentation

    by Hye Jin Chung, Danielle R. Rinck, Li‐Chi Chen, Steven R. Tahan

    Background: Dermal postinflammatory hyperpigmentation (PIH) is frequently refractory to treatment, and therapeutic response is thought to depend on the depth and distribution of dermal pigment. Key quantitative histopathologic features, however, remain poorly defined. Methods: Ninety‐five biopsy‐proven cases of dermal PIH were analyzed. Fontana–Masson–stained sections underwent image analysis to quantify epidermal and dermal pigmentation intensity, melanophage density, cross‐sectional area, and depth. Associations with inflammatory etiology, Fitzpatrick skin type (FST), and sun‐exposure status of the biopsy site were assessed. Results: Epidermal pigmentation intensity was significantly increased in spongiotic dermatitis, higher FST, and sun‐exposed sites. Dermal pigmentation intensity was associated with sun exposure. Melanophage density increased with higher FST but was lower in spongiotic dermatitis compared with lichenoid and vacuolar interface dermatitis. In contrast, melanophage cross‐sectional area and depth showed no significant associations with etiology, FST, or anatomic site. Median melanophage depth was 295.0 μm (IQR, 220.0–407.0 μm) from stratum corneum and 163.0 μm (IQR, 111.2–235.5 μm) from basement membrane, with consistent measurements across subgroups. Conclusion: Despite variability in epidermal pigmentation and melanophage density, melanophage depth is uniform across dermal PIH. These findings refine the conventional epidermal‐dermal PIH classification and support a quantitative, anatomy‐based framework to inform depth‐targeted treatment strategies.

  • Histologic margin involvement by cutaneous basal cell carcinoma stroma: a retrospective cohort study for residual or recurrent carcinoma

    by Danielle R Rinck, Steven R Tahan

    Aim: The clinical significance of histologic margin involvement by basal cell carcinoma (BCC)-associated stroma remains uncertain. This study aimed to determine the incidence of residual BCC in immediate re-excision specimens or clinical recurrence in cases managed without re-excision. Methods: Fifty-eight cases of BCC with stromal margin involvement diagnosed between 2016 and 2020 were retrospectively reviewed. Fifty cases underwent immediate surgical re-excision, and eight were managed with clinical observation for at least two years. Tumors were classified by histologic subtype, and stromal margin involvement was categorized as peripheral, deep, or both. Residual carcinoma on re-excision or clinical recurrence within two years was recorded. Results: Residual carcinoma was identified in 8% of re-excised cases (4/50) and occurred exclusively in tumors with a superficial component, including three pure superficial BCCs and one mixed superficial-nodular BCC; all residual tumors were of superficial subtype. No residual carcinoma was observed among 23 nodular or infiltrative BCCs that underwent re-excision. None of the eight cases managed with observation (1 superficial, 2 mixed superficial-nodular, 5 nodular) demonstrated clinical recurrence within two years. Overall, residual or recurrent disease occurred in 7% of cases (4/58). The distribution of adverse outcomes differed significantly by histologic subtype. Conclusions: Stromal margin involvement in non-superficial BCCs is rarely associated with residual or recurrent carcinoma. Adverse outcomes were confined to tumors containing a superficial component, highlighting biologic heterogeneity among BCC subtypes. These findings suggest that routine re-excision may be unnecessary for stromal-margin-positive BCCs lacking a superficial component and support more selective, subtype-informed management.

  • Martin C. Mihm, Jr. and Dermatopathology Education at Harvard Medical School

    by Lyn M. Duncan, Steven R. Tahan, Mai P. Hoang, George F. Murphy

  • Colloid Bodies in Cutaneous Basal Cell Carcinoma: Clinical and Histologic Correlates—An Analysis of 405 Cases

    by Ruben Oganesyan, Steven R. Tahan

    Background: Colloid bodies (CB), also known as Civatte bodies, are commonly seen in inflammatory dermatoses and are thought to represent cell degeneration. No studies have investigated the incidence and clinical associations of CB in cutaneous basal cell carcinoma (BCC). The aim of this study is to assess the incidence of CB in BCC lesions and analyze their clinical associations. Methods: Four hundred and five sequential cases of cutaneous BCC from 396 patients diagnosed from 1/1/2023 to 12/31/2023 in our institution were studied for the presence of CB. Only cases of BCC with a single growth pattern were included. BCC subtype, patient age, location of the lesion, history of previous BCC at other site, smoking history, and allergy history were collected. Cases with and without CB were compared for each parameter using the paired t‐test for age and the Chi‐square test for categorical data. Results: Patients were grouped based on the presence of CB into a study group (57 cases) and control group with no CB (348 cases). CB were identified in 14% (57/405) of BCCs. 19% (54/281) of nodular, 12.5% (1/8) of infiltrative, and 1.7% (2/116) of superficial type BCCs had CB. BCC with CB were more common on the face/scalp than other sites (66.7% vs. 34.2%, p < 0.001). Patients with CB were older (median 72 vs. 68 years ±12, p = 0.04), predominantly male (63% vs. 47%, p = 0.02), more frequently had a prior BCC (0.61% vs. 0.38%, p = 0.012), and did not differ in smoking history compared to the control cohort. Conclusions: We identified CB in 14% of BCCs studied, most commonly in nodular, followed by infiltrative, and least often superficial type. After cohort matching, significant clinical associations of CB in BCC were sun‐exposed location and personal history of one or more prior BCC at other site(s). Their pathogenesis is not known, however their presence suggests tumor regression, which may potentially be exploited for new therapies in a subset of patients.


  • Invasion risk of cutaneous squamous cell carcinoma in situ by histological subtype: a retrospective cohort study

    by Danielle K Stamer, Joshua Goldsmith, Laura E Dodge, Steven R Tahan

    Aims Cutaneous squamous cell carcinoma in situ (SCCis) can be classified histopathologically into four subtypes: full-thickness (FT), hypertrophic actinic keratosis (HAK), Bowenoid, and acantholytic types. 3%–5% of SCCis lesions progress to invasive squamous cell carcinoma (iSCC), however progression risk by subtype has not been assessed. Aim one of this study is to quantitatively assess the risk of iSCC associated with each histological subtype of SCCis. Aim two is to evaluate if the histological grade of iSCC differs among subtypes of the associated SCCis. Methods The pathology information system at our institution was queried for cutaneous SCCis cases with and without associated iSCC from 2020 to 2022. The study group consisted of 65 cases of SCCis with associated iSCC and control group 65 randomly selected cases of SCCis without invasion. For each case SCCis subtype was classified as FT, HAK, Bowenoid or acantholytic type. iSCCs were classified as low grade if well to moderately differentiated (LG) and high grade (HG) if moderately to poorly differentiated. Results iSCC was most often associated with HAK-type SCCis, followed by acantholytic and FT-type SCCis, with Bowenoid type rarely associated with iSCC. 41% (14/34) of iSCCs associated with HAK-type SCCis were HG compared with 84% (21/25) for FT-type SCCis. Conclusions iSCC is most often associated with HAK-type SCCis, followed by acantholytic and FT-types, and rarely with Bowenoid type. HG invasive SCC is most often associated with FT-type, and LG with HAK-type SCCis. Stratifying SCCis by subtype can inform clinical management.

  • Clonal-pattern Seborrheic Keratosis

    by Joshua F. Do Goldsmith, Laleh Montaser Kouhsari, Steven R. Tahan

    Seborrheic keratosis is a benign epidermal tumor. Seborrheic keratosis with clonal pattern (CPSK) displays histologic features distinct from other subtypes of SK (non-CPSK). We sought to quantitatively assess the risk of recurrence and progression to squamous cell carcinoma (SCC), either in situ or invasive, of incompletely excised CPSKs. We studied all 244 cases from 238 patients of “seborrheic keratosis, clonal pattern” diagnosed in our institution over a 10-year period (2008-2018). Demographic, clinical, pathologic, and follow-up data were gleaned from electronic health records. Following glass slide review, CPSK lesions were divided into 2 groups: CPSK with cytologic atypia and CPSK without cytologic atypia. For comparison, 107 non-CPSKs were studied as controls. The minimum follow-up period was 2 years (median=4 y). All lesions were incompletely excised. Eighteen of 244 CPSKs (7.4%) recurred at or adjacent to the site of initial partial removal compared with 1.9% of non-CPSKs. Five of the 18 (28%) recurrent CPSKs recurred as CPSK, 11 (61%) as SCC in situ, and 3 (17%) as invasive SCC. The mean time to recurrence was 3.1 years. Two non-CPSKs recurred as non-CPSKs. Overall CPSKs were more likely to recur than non-CPSKs (P=0.04). CPSKs with atypia were more likely to recur than CPSKs without atypia (P=0.03). The upgrade rate to SCC at least in situ of all recurrent CPSK lesions with atypia was 78%. Our results suggest that pathologists should report the presence of clonal pattern when observed in seborrheic keratoses, indicate the presence of atypia, and provide lesional margin assessment.


  • Dogliotti and Phillips classifications are unsuitable for grading the histopathological findings of exogenous ochronosis

    by Maximiliano Ramia de Cap, Xenia Parisi, Steven R. Tahan

    Background: Cutaneous exogenous ochronosis (EO) is frequently graded and staged according to the Dogliotti or Phillips classification system, both in research studies and in clinical practice. There are no data to support the use of these systems in either of these settings. These systems additionally purport that the clinical and histopathological findings of EO are concordant; however, anecdotal evidence suggests otherwise. We aimed to determine the clinical‐histopathological concordance rates in EO and to assess the suitability of the Dogliotti and Phillips classification systems for the grading and staging of EO lesions.Methods: Five cutaneous EO cases diagnosed at our institution were studied. Clinical and histopathological data were obtained by medical record and histopathology slide review. Each case was assigned a clinical and histopathological grade according to both the Dogliotti and Phillips classifications. Clinical‐histopathological concordance rates were determined for each classification.Results: Clinical‐histopathological concordance was seen in 80% and 60% of EO lesions when graded according to the Dogliotti and Phillips classifications, respectively.Conclusions: Cutaneous EO lesions do not consistently show clinical‐histopathological concordance. Although the Dogliotti and Phillips classifications may have clinical utility, they are not suitable to grade EO histopathologically.


  • Intralymphatic histiocytosis in healing cellulitis: Case report and review of the literature

    by Joshua F. Goldsmith, Steven R. Tahan

    Intralymphatic histiocytosis (ILH) is a rare skin benign condition observed in a variety of inflammatory settings. It is characterized by the presence of ectatic dermal lymphatic vessels containing aggregates of histiocytes. Associated conditions that have been identified include rheumatoid arthritis, metallic orthopedic implants, inflammatory bowel disease, and malignancies of the breast, skin, and colon. Some cases with no attributable underlying cause have been described. The pathophysiology of ILH is not well understood. It has been proposed that it may represent macrophage migration during immune activation. Herein, we present the first description of ILH observed in the healing phase of cellulitis on the skin of the breast. Awareness of this possibility is important when the diagnosis of intravascular carcinomatosis is being considered.